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Background
Identifying women in the US with sufficient risk of HIV
infection for inclusion in HIV vaccine efficacy trials has
been challenging. Using geography and sexual network
characteristics to inform new recruitment strategies,
HVTN 906 determined the feasibility of recruiting and
retaining women at high risk and assessed HIV incidence.
Methods
HIV uninfected women were enrolled in Chicago, New
York City and Philadelphia if they were 18-45 years, not
pregnant or intending to become pregnant for 18 months
and reported unprotected vaginal/anal sex in the prior six
months and either i) resided or engaged in risk behavior
in local geographical HIV risk pockets; and/or ii) had a
male partner who had either been incarcerated or injected
drugs in the last year or had concurrent sex with another
partner in the last six months. Behavioral risk assessment,
risk reduction counseling, HIV and pregnancy testing
were done at baseline, 6, 12 and 18 months.
Results
Among 799 women, 71% were from local high-risk pock-
ets and had high-risk male partners, 18% were from local
high-risk pockets only and 10% had high-risk male part-
ners only. Median age was 37 years; 79% were Black and
15% Latina. At baseline, the median number of male part-
ners was 3 (25%,75%: 2,7), 76% had unprotected sex while
intoxicated (alcohol or drugs), and 52% exchanged sex for
money or drugs. Retention at 18-months was 80%. Preg-
nancy incidence was 11% with 48% of pregnancies occur-
ring during the first 6 months of follow-up. HIV incidence
was 0.31% (95% CI: 0.06,0.91). Risk behaviors decreased
between screening and 6 months with little change
thereafter.
Conclusion
Women recruited using new strategies based on geogra-
phy and sexual network characteristics did not have a sub-
stantial HIV incidence, despite baseline levels of risk
behaviors. New strategies to identify women at high risk in
the US are needed.
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